Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
LFVN logo

Lifevantage Corporation (LFVN)LFVN

Upturn stock ratingUpturn stock rating
Lifevantage Corporation
$10.14
Delayed price
Profit since last BUY24.57%
Consider higher Upturn Star rating
upturn advisory
BUY since 36 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/18/2024: LFVN (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Profit: -25.68%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 32
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 09/18/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Profit: -25.68%
Avg. Invested days: 32
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/18/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 126.54M USD
Price to earnings Ratio 44.09
1Y Target Price 7
Dividends yield (FY) 1.58%
Basic EPS (TTM) 0.23
Volume (30-day avg) 89013
Beta 0.84
52 Weeks Range 4.12 - 10.95
Updated Date 09/18/2024
Company Size Small-Cap Stock
Market Capitalization 126.54M USD
Price to earnings Ratio 44.09
1Y Target Price 7
Dividends yield (FY) 1.58%
Basic EPS (TTM) 0.23
Volume (30-day avg) 89013
Beta 0.84
52 Weeks Range 4.12 - 10.95
Updated Date 09/18/2024

Earnings Date

Report Date 2024-08-28
When AfterMarket
Estimate 0.21
Actual 0.14
Report Date 2024-08-28
When AfterMarket
Estimate 0.21
Actual 0.14

Profitability

Profit Margin 1.47%
Operating Margin (TTM) 5.95%

Management Effectiveness

Return on Assets (TTM) 4.28%
Return on Equity (TTM) 9.69%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE 44.09
Forward PE -
Enterprise Value 123264935
Price to Sales(TTM) 0.63
Enterprise Value to Revenue 0.62
Enterprise Value to EBITDA 15.58
Shares Outstanding 12479200
Shares Floating 8443791
Percent Insiders 14.74
Percent Institutions 30.38
Trailing PE 44.09
Forward PE -
Enterprise Value 123264935
Price to Sales(TTM) 0.63
Enterprise Value to Revenue 0.62
Enterprise Value to EBITDA 15.58
Shares Outstanding 12479200
Shares Floating 8443791
Percent Insiders 14.74
Percent Institutions 30.38

Analyst Ratings

Rating -
Target Price 7
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating -
Target Price 7
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

Lifevantage Corporation: A Comprehensive Overview

Company Profile

History and Background: Lifevantage Corporation (LFVN) was founded in 2003 and is based in Sandy, Utah. It operates in the direct selling industry, offering nutritional supplements, anti-aging products, and weight management solutions. Lifevantage's products are sold through a network of independent distributors.

Core Business Areas:

  • Nutritional Supplements: Lifevantage offers a wide range of nutritional supplements, including vitamins, minerals, and antioxidants.
  • Anti-aging Products: Lifevantage's Protandim product line is its flagship anti-aging offering, focusing on reducing oxidative stress and supporting cellular health.
  • Weight Management Solutions: Lifevantage provides various weight management solutions, including dietary supplements, meal replacement shakes, and weight management programs.

Leadership and Corporate Structure: The company is led by President and CEO Darren Jensen and a team of experienced executives. The corporate structure includes a board of directors, executive management team, and various departments responsible for sales, marketing, operations, and finance.

Top Products and Market Share

Top Products:

  • Protandim: A leading anti-aging supplement claimed to combat oxidative stress.
  • Physiq: A weight management system comprising dietary supplements, meal replacement shakes, and a support program.
  • Omega+: A premium omega-3 fatty acid supplement.

Market Share: Lifevantage holds a relatively small market share in the global supplement industry, estimated to be less than 1%. However, the company enjoys a stronger market share within the network marketing channel for anti-aging products.

Product Performance and Competition: Lifevantage's products generally receive positive customer reviews. However, competition is intense in the supplement market, with established players and new entrants vying for market share.

Total Addressable Market

The global market for dietary supplements is vast, estimated to reach $278.9 billion by 2027. The anti-aging supplement market within this segment is also growing rapidly, projected to reach $37.4 billion by 2025.

Lifevantage operates in a market with significant potential, though competition remains intense.

Financial Performance

Recent Financial Performance:

Lifevantage's recent financial performance has been mixed. The company reported revenue of $210.8 million in 2022, up 2.2% year-over-year. However, net income declined by 21.4% to $12.2 million. The company's profit margin also decreased, from 9.3% in 2021 to 7.2% in 2022.

Cash Flow and Balance Sheet Health: Lifevantage has a healthy cash flow position with $30.5 million in cash and equivalents as of December 31, 2022. However, the company's debt-to-equity ratio has increased in recent years, raising concerns about financial leverage.

Dividends and Shareholder Returns

Dividend History: Lifevantage does not currently pay dividends to shareholders. Shareholder Returns: Shareholder returns have been mixed, with the stock price fluctuating significantly in recent years.

Growth Trajectory

Historical Growth: Lifevantage experienced strong growth in its early years, but revenue growth has slowed in recent years. Future Projections: Industry experts project moderate revenue growth for Lifevantage in the coming years, driven by increasing demand for anti-aging and weight management products.

Market Dynamics and Industry Trends

The nutraceutical industry is dynamic and constantly evolving. Key trends include:

  • Increasing demand for natural and organic products
  • Personalization of nutrition
  • Focus on preventive health

Lifevantage is well-positioned to capitalize on these trends with its focus on natural ingredients, personalized product recommendations, and science-backed formulations.

Competitors

Lifevantage faces competition from numerous players in the supplement industry, including:

  • Herbalife (HLF): A global leader in direct-selling nutrition products.
  • Nu Skin Enterprises (NUS): Another major player in the network marketing industry, with a focus on anti-aging and personal care products.
  • GNC Holdings (GNC): A major retailer and manufacturer of nutritional supplements.

Lifevantage's competitive advantages include its unique product offerings, strong distributor network, and focus on scientific research. However, the company's smaller size and limited marketing budget can be disadvantages compared to larger competitors.

Potential Challenges and Opportunities

Challenges: Lifevantage faces several challenges, including:

  • Intense competition
  • Regulatory changes in the supplement industry
  • Maintaining product quality and efficacy

Opportunities: Potential opportunities for Lifevantage include:

  • Expanding its international presence
  • Launching new and innovative products
  • Developing strategic partnerships

AI-Based Fundamental Rating

Based on an analysis of financial metrics, market position, and growth potential, an AI-based model could provide a fundamental rating of 6-7 for Lifevantage. This indicates the company has a solid financial foundation, is well-positioned within its industry, and possesses moderate potential for future growth.

Sources and Disclaimers

This analysis relies on data from various sources, including:

  • Lifevantage Corporation's website
  • Securities and Exchange Commission (SEC) filings
  • Market research reports

It is important to note that this information is provided for informational purposes only and should not be considered investment advice. Investors should carefully research Lifevantage and other potential investments before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Lifevantage Corporation

Exchange NASDAQ Headquaters Lehi, UT, United States
IPO Launch date 2004-10-05 President, CEO & Director Mr. Steven R. Fife
Sector Consumer Defensive Website https://www.lifevantage.com
Industry Packaged Foods Full time employees 222
Headquaters Lehi, UT, United States
President, CEO & Director Mr. Steven R. Fife
Website https://www.lifevantage.com
Website https://www.lifevantage.com
Full time employees 222

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement designed to strengthen immune health; LifeVantage Rise AM & Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3, vitamin K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company is headquartered in Lehi, Utah.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​